modulates the expression of JAK-STAT signaling components to attenuate the Type II interferon response of epithelial cells

Francis L. Fontanilla,Rey A. Carabeo,Amanda J. Brinkworth
DOI: https://doi.org/10.1101/2024.01.09.574898
2024-01-10
Abstract:has adapted to subvert signaling in epithelial cells to ensure successful intracellular development. Interferon-γ (IFNγ) produced by recruited lymphocytes signals through the JAK/STAT pathway to restrict chlamydial growth in the genital tract. However, during infection , addition of IFNγ does not fully induce nuclear localization of its transcription factor STAT1 and target gene, IDO1. We hypothesize that this altered interferon response is a result of targeting components of the IFNγ-JAK/STAT pathway. To assess the ability of replicating to dampen interferon signaling, HEp2 human epithelial cells were infected with serovar L2 for 24 hours prior to exposure to physiologically relevant levels of IFNγ (500 pg/mL). This novel approach enabled us to observe reduced phospho-activation of both STAT1 and its kinase Janus Kinase 2 (JAK2) in infected cells compared to mock-infected cells. Importantly, basal JAK2 and STAT1 transcript and protein levels were dampened by infection even in the absence of interferon, which could have implications for cytokine signaling beyond IFNγ. Additionally, target genes IRF1, GBP1, APOL3, IDO1, and SOCS1 were not fully induced in response to IFNγ exposure. Infection-dependent decreases in transcript, protein, and phosphoprotein were rescued when bacterial protein synthesis was inhibited with chloramphenicol, restoring expression of IFNγ-target genes. Similar -dependent dampening of STAT1 and JAK2 transcript levels were observed in infected END1 endocervical cells and in HEp2s infected with serovar D, suggesting a conserved mechanism of dampening the interferon response by reducing the availability of key signaling components.
Microbiology
What problem does this paper attempt to address?